A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens

Vaccine

Volumn 32, Issue 28, 2014, Pages 3555-3563

  Kanabagatte Basavarajappa, Mallikarjuna ^a   Kumar, Sachin ^a,b   Khattar, Sunil K ^a   Gebreluul, Girmay T ^a   Paldurai, Anandan ^a   Samal, Siba K ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b INDIAN INSTITUTE OF TECHNOLOGY GUWAHATI   (India)

Author keywords

Glycoprotein B; Glycoprotein C; Glycoprotein D; Immunogenicity; Infectious laryngotracheitis virus; Newcastle disease virus vector

Indexed keywords

GLYCOPROTEIN B; GLYCOPROTEIN D; NEUTRALIZING ANTIBODY; PROTEIN C; VACCINE; GLYCOPROTEIN D, GALLID HERPESVIRUS 1; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SURFACE; CHICKEN; HISTOPATHOLOGY; ILTOVIRUS; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE GENETICS; TRACHEA; VIRUS RECOMBINANT; ANIMAL; BLOOD; GENE VECTOR; GENETICS; HEMAGGLUTINATION INHIBITION TEST; HERPESVIRIDAE INFECTIONS; IMMUNOLOGY; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; PATHOLOGY; POULTRY DISEASES; SERODIAGNOSIS;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHICKENS; GENETIC VECTORS; HEMAGGLUTINATION INHIBITION TESTS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, GALLID; NEUTRALIZATION TESTS; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; POULTRY DISEASES; TRACHEA; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 84901464928     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.04.068     Document Type: Article

References (46)

1. Bagust T.J., Jones R.C., Guy J.S. Avian infectious laryngotracheitis. Rev Sci Tech 2000, 19(2):483-492.
2. Bagust T.J. Laryngotracheitis (Gallid-1) herpesvirus infection in the chicken: 4. Latency establishment by wild and vaccine strains of ILT virus. Avian Pathol 1986, 15(3):581-595.
3. Guy J.S., Barnes H.J., Smith L. Increased virulence of modified-live infectious laryngotracheitis vaccine virus following bird-to-bird passage. Avian Dis 1991, 35(2):348-355.
4. Hughes C.S., Williams R.A., Gaskell R.M., Jordan F.T., Bradbury J.M., Bennett M., et al. Latency and reactivation of infectious laryngotracheitis vaccine virus. Arch Virol 1991, 121(1-4):213-218.
5. Coppo Mauricio J.C., Noormohammadi Amir H., Browning Glenn F., Devl Joanne M. Challenges and recent advancements in infectious laryngotracheitis virus vaccines. Avian Pathol 2013, 42(3):195-205.
6. Lee S.-W., Markham P.F., Coppo M.J.C., Legione A.R., Markham J.F., Noormohammadi A.F., et al. Attenuated vaccines can recombine to form virulent field viruses. Science 2012, 337(6091):188.
7. Henderson L.M., Levings R.L., Davis A.J., Sturtz D.R. Recombination of pseudorabies virus vaccine strains in swine. Am J Vet Res 1991, 52(6):820-825.
8. Tong G.Z., Zhang S.J., Wang L., Qiu H.J., Wang Y.F., Wang M. Protection of chickens from infectious laryngotracheitis with a recombinant fowlpox virus expressing glycoprotein B of infectious laryngotracheitis virus. Avian Pathol 2001, 30(2):143-148.
9. Sun H.L., Wang Y.F., Tong G.Z., Zhang P.J., Miao D.Y., Zhi H.D., et al. Protection of chickens from Newcastle disease and infectious laryngotracheitis with a recombinant fowlpox virus co-expressing the F, HN genes of Newcastle disease virus and gB gene of infectious laryngotracheitis virus. Avian Dis 2008, 52(1):111-117.
10. Vagnozzi A., Zavala G., Riblet S.M., Mundt A., García M. Protection induced by commercially available live-attenuated and recombinant viral vector vaccines against infectious laryngotracheitis virus in broiler chickens. Avian Pathol 2012, 41(1):21-31.
11. Fuchs W., Veits J., Helferich D., Granzow H., Teifke J.P., Mettenleiter T.C. Molecular biology of avian infectious laryngotracheitis virus. Vet Res 2007, 38(2):261-279.
12. York J.J., Fahey K.J. Vaccination with affinity-purified glycoproteins protects chickens against infectious laryngotracheitis herpesvirus. Avian Pathol 1991, 20(4):693-704.
13. Fauquet C.M., Mayo M.A., Maniloff J., Desselberger U., Ball L.A. Virus taxonomy: VIIIth report of the international committee on taxonomy of viruses 2005, Elsevier Academic Press, San Diego.
14. Steward M., Vipond I.B., Millar N.S., Emmerson P.T. RNA editing in Newcastle disease virus. J Gen Virol 1993, 74(Pt 12):2539-2547.
15. Nayak B., Rout S.N., Kumar S., Khalil M.S., Fouda M.M., Ahmed L.E., et al. Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses. PLoS ONE 2009, 4(8):e6509.
16. Huang Z., Elankumaran S., Yunus A.S., Samal S.K. A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV. J Virol 2004, 78(18):10054-10063.
17. Huang Z., Krishnamurthy S., Panda A., Samal S.K. High-level expression of a foreign gene from the most 3'-proximal locus of a recombinant Newcastle disease virus. J Gen Virol 2001, 82:1729-1736.
18. Khattar S.K., Collins P.L., Samal S.K. Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1. Vaccine 2010, 28(18):3159-3170.
19. Khattar S.K., Samal S., Devico A.L., Collins P.L., Samal S.K. Newcastle disease virus expressing human immunodeficiency virus type 1 envelope glycoprotein induces strong mucosal and serum antibody responses in Guinea pigs. J Virol 2011, 85(20):10529-10541.
20. Nayak B., Kumar S., DiNapoli J.M., Paldurai A., Perez D.R., Collins P.L., et al. Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunity. J Virol 2010, 84(5):2408-2420.
21. Oldoni I., Rodriguez-Avila A., Riblet S.M., Zavala G., Garcia M. Pathogenicity and growth characteristics of selected infectious laryngotracheitis virus strains from the United States. Avian Pathol 2009, 38(1):47-53.
22. Hierholzer J.C., Killington R.A. Virus isolation and quantitation. Virology methods manual 1996, Academic Press, London, United Kingdom. B.W. Mahy, H.I. Kangro (Eds.).
23. Poulsen David J., Keeler Calvin L. Characterization of the assembly and processing of infectious laryngotracheitis virus glycoprotein B. J Gen Virol 1997, 78:2945-2951.
24. Alexander D.J. Newcastle disease. A laboratory manual for the isolation and identification of avian pathogens 1989, 114-120. American Association for Avian Pathologists Inc., Kennett Square, PA. 3rd ed. H.G. Purchase, L.H. Arp, C.H. Domermuth, J.E. Pearson (Eds.).
25. Fischer L., Barzu S., Andreoni C., Buisson N., Brun A., Audonnet J.C. DNA vaccination of neonate piglets in the face of maternal immunity induces humoral memory and protection against a virulent pseudorabies virus challenge. Vaccine 2003, 21(15):1732-1741.
26. Hong W., Xiao S., Zhou R., Fang L., He Q., Wu B., et al. Protection induced by intramuscular immunization with DNA vaccines of pseudorabies in mice, rabbits and piglets. Vaccine 2002, 20(7/8):1205-1214.
27. Lukacs N., Thiel H.J., Mettenleiter T.C., Rziha H.J. Demonstration of three major species of pseudorabies virus glycoproteins and identification of a disulfide-linked glycoprotein complex. J Virol 1985, 53(1):166-173.
28. Hampl H., Ben-Porat T., Ehrlicher L., Habermehl K.O., Kaplan A.S. Characterization of the envelope proteins of pseudorabies virus. J Virol 1984, 52(2):583-590.
29. Zuckermann F.A., Zsak L., Mettenleiter T.C., Ben-Porat T. Pseudorabies virus glycoprotein gIII is a major target antigen for murine and swine virus-specific cytotoxic T lymphocytes. J Virol 1990, 64(2):802-812.
30. + memory T-helper cells in swine. J Virol 1998, 72(6):4866-4873.
31. Babiuk L.A., L'Italien J., van Drunen Littel-van den Hurk S., Zamb T., Lawman J.P., Hughes G., et al. Protection of cattle from bovine herpesvirus type I (BHV-1) infection by immunization with individual viral glycoproteins. Virology 1987, 159(1):57-66.
32. Chase C.C., Carter-Allen K., Letchworth G.J. The effect of bovine herpesvirus type 1 glycoproteins gI and gIII on herpesvirus infections. J Gen Virol 1989, 70(Pt 6):1561-1569.
33. van Drunen Littel-van den Hurk S., Gifford G.A., Babiuk L.A. Epitope specificity of the protective immune response induced by individual bovine herpesvirus-1 glycoproteins. Vaccine 1990, 8(4):358-368.
34. Gao Y., Leary T.P., Eskra L., Splitter G.A. Truncated bovine herpesvirus-1 glycoprotein I (gpI) initiates a protective local immune response in its natural host. Vaccine 1994, 12(2):145-152.
35. Zhu X., Letchworth G.J. Mucosal and systemic immunity to bovine herpesvirus-1 glycoprotein D confer resistance to viral replication and latency in cattle. Vaccine 1996, 14(1):61-69.
36. Roberts A., Reuter J.D., Wilson J.H., Baldwin S., Rose J.K. Complete protection from papillomavirus challenge after a single vaccination with a vesicular stomatitis virus vector expressing high levels of L1 protein. J Virol 2004, 78(6):3196-3199.
37. Chen H.Y., Cui P., Cui B.A., Li H.P., Jiao X.Q., Zheng L.L., et al. Immune responses of chickens inoculated with a recombinant fowlpox vaccine coexpressing glycoprotein B of infectious laryngotracheitis virus and chicken IL-18. FEMS Immunol Med Microbiol 2011, 63(2):289-295.
38. Bennett A.M., Slomka M.J., Brown D.W., Lloyd G., Mackett M. Protection against herpes B virus infection in rabbits with a recombinant vaccinia virus expressing glycoprotein D. J Med Virol 1999, 57(1):47-56.
39. Zakhartchouk A.N., Pyne C., Mutwiri G.K., Papp Z., Baca-Estrada M.E., Griebel P., et al. Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1. J Gen Virol 1999, 80(Pt 5):1263-1269.
40. Heineman T.C., Pesnicak L., Ali M.A., Krogmann T., Krudwig N., Cohen J.I. Varicella-zoster virus expressing HSV-2 glycoproteins B and D induces protection against HSV-2 challenge. Vaccine 2004, 22(20):2558-2565.
41. Rauw P., Gardin Y., Palya V., Anbari S., Lemaire S., Boschmans M., et al. Improved vaccination against Newcastle disease by an in ovo recombinant HVT-ND combined with an adjuvanted live vaccine at day-old. Vaccine 2010, 28(3):823-833.
42. DiNapoli J.M., Yang L., Suguitan A., Elankumaran S., Dorward D.W., Murphy B.R., et al. Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus. J Virol 2007, 81(21):11560-11568.
43. York J.J., Fahey K.J. Humoral and cell-mediated immune responses to the glycoproteins of infectious laryngotracheitis herpesvirus. Arch Virol 1990, 115(3/4):289-297.
44. Fahey K.J., York J.J. The role of mucosal antibody in immunity to infectious laryngotracheitis virus in chickens. J Gen Virol 1990, 71(Pt 10):2401-2405.
45. Fahey K.J., Bagust T.J., York J.J. Laryngotracheitis herpesvirus infection in the chicken: the role of humoral antibody in immunity to a graded challenge infection. Avian Pathol 1983, 12:505-514.
46. Honda T., Okamura H., Taneno A., Yamada S., Takahashi E. The role of cell-mediated immunity in chickens inoculated with the cell-associated vaccine of attenuated infectious laryngotracheitis virus. J Vet Med Sci 1994, 56:1051-1055.